SEC Comment Letter 0000000000-25-001719 to Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Date: Feb. 14, 2025 · CIK: 0000922247 · Accession: 0000000000-25-001719
AI Filing Summary & Sentiment
File numbers found in text: 001-39780
Letter
February 14, 2025 Joshua M. Fine Chief Financial Officer Cyclo Therapeutics, Inc. 6714 NW 16th Street, Suite B Gainesville, Florida 32653 Re:Cyclo Therapeutics, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-39780 Filed March 18, 2024 Dear Joshua M. Fine: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Alison Newman
Show Raw Text
February 14, 2025
Joshua M. Fine
Chief Financial Officer
Cyclo Therapeutics, Inc.
6714 NW 16th Street, Suite B
Gainesville, Florida 32653
Re:Cyclo Therapeutics, Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-39780
Filed March 18, 2024
Dear Joshua M. Fine:
We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Alison Newman